Patents Assigned to INSERM, INTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
  • Bromide source for use in treating autism spectral disorder
    Patent number: 11666599
    Abstract: The present invention relates to a novel pharmaceutical use of bromide, i.e. the treatment of autism spectral disorder (ASD).
    Type: Grant
    Filed: November 28, 2017
    Date of Patent: June 6, 2023
    Assignees: INSERM, INTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE, INRA, INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE, CNRS, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE DE STRASBOURG
    Inventors: Sébastien Roux, Thierry Plouvier, Julie Le Merrer, Jérôme Becker